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Abstract
Background and purpose
Vitamin D deficiency (VDD) is a global health problem, which can lead to several pathophys-
iological consequences including cardiovascular diseases. Its impact on the cerebrovascu-
lar system is not well understood. The goal of the present work was to examine the effects
of VDD on the morphological, biomechanical and functional properties of cerebral arterioles.
Methods
Four-week-old male Wistar rats (n = 11 per group) were either fed with vitamin D deficient
diet or received conventional rat chow with per os vitamin D supplementation. Cardiovascu-
lar parameters and hormone levels (testosterone, androstenedione, progesterone and 25-
hydroxyvitamin D) were measured during the study. After 8 weeks of treatment anterior
cerebral artery segments were prepared and their morphological, biomechanical and func-
tional properties were examined using pressure microangiometry. Resorcin-fuchsin and
smooth muscle actin staining were used to detect elastic fiber density and smooth muscle
cell counts in the vessel wall, respectively. Sections were immunostained for eNOS and
COX-2 as well.
Results
VDD markedly increased the wall thickness, the wall-to-lumen ratio and the wall cross-sec-
tional area of arterioles as well as the number of smooth muscle cells in the tunica media. As
a consequence, tangential wall stress was significantly lower in the VDD group. In addition,
VDD increased the myogenic as well as the uridine 5’-triphosphate-induced tone and
impaired bradykinin-induced relaxation. Decreased eNOS and increased COX-2 expression
were also observed in the endothelium of VDD animals.
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Conclusions
VDD causes inward hypertrophic remodeling due to vascular smooth muscle cell prolifera-
tion and enhances the vessel tone probably because of increased vasoconstrictor prosta-
noid levels in young adult rats. In addition, the decreased eNOS expression results in
endothelial dysfunction. These morphological and functional alterations can potentially com-
promise the cerebral circulation and lead to cerebrovascular disorders in VDD.
Introduction
Vitamin D deficiency (VDD) or insufficiency affects 1 billion people from all age groups
worldwide. In addition to its well-characterized roles in calcium and phosphate homeostasis as
well as in bone metabolism, 1,25-dihydroxyvitamin D—the active metabolite of vitamin D
(VitD)—has numerous biological actions [1]. Besides interacting with the intracellular VitD
receptor and regulating the expression of up to 200 genes, it mediates non-genomic actions as
well [2]. VDD is associated with an increased risk of malignant tumor formation, autoimmune
and infectious diseases as well as depression [1]. Diabetes mellitus and metabolic syndrome
are also linked to VDD, as 1,25-dihydroxyvitamin D improves β-cell function and insulin
sensitivity [3]. There is a growing body of evidence linking VDD to cardiovascular diseases
including hypertension, atherosclerosis and coronary artery disease. Furthermore, a direct
impact of VDD on endothelial dysfunction, arterial stiffness and vascular inflammation was
also reported [2, 4, 5].
The effects of VDD on the cerebrovascular system are as yet less understood, although sev-
eral studies highlight the importance of sufficient VitD status in cerebrovascular health. Low
concentrations of VitD are associated with an increased risk of cerebrovascular diseases
including ischemic stroke [6–9] and with poor poststroke outcome [10]. In addition, VDD is
linked to chronic brain injury associated with cerebral small vessel disease [11]. The effect of
VitD status on stroke severity was confirmed in rodent models as well: the infarction volume
was larger and more severe poststroke behaviour impairment was observed in VitD-deficient
rats as compared to VitD-sufficient ones [12].
In the present study, we hypothesized that the aforementioned adverse effects of VDD in
stroke are related—at least in part—to VDD-induced alterations in cerebral arterioles. There-
fore, we aimed to analyze the changes in the morphological, biomechanical and functional
properties of the anterior cerebral artery (ACA) in a rodent model of VDD.
Materials and methods
Animals
All procedures conformed to the Guide for the Care and Use of Laboratory Animals published
by the US National Institutes of Health (8th edition, 2011) and the EU-conform Hungarian
Law on Animal Care (XXVIII/1998). The Institutional Animal Care and Use Committee of
Semmelweis University approved the study protocol (IRB: 8/2014, PEI/001/1548-3/2014). All
surgery was performed under sodium pentobarbital anesthesia, and all efforts were made to
minimize suffering. Twenty-two 4-week-old male Wistar rats were involved in the experi-
ments. Eleven of them were fed with VitD-deficient diet (VitD content less than 5 IU/kg) for
eight weeks (VDD group). Control animals received conventional rat chow (containing 1500
IU/kg VitD) with per os VitD (Vigantol, 20.000 IU/mL cholecalciferol) supplementation (at
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the second week of the study 500 IU/100 g body weight as loading dose, then 140 IU/100 g b.
w. weekly from week 4 to 7 as maintenance dose). Taken together, the daily VitD intake in the
Control group was approximately 300 IU/100 g b. w. providing optimal VitD supply. Serum
25-hydroxyvitamin D, testosterone, androstenedione and progesterone levels were measured
from blood samples taken at weeks 4 and 8. At week 6 a glucose tolerance test was performed:
fasting as well as 60-minute and 120-minute postload plasma levels were measured before and
after oral administration of 2 g/kg b. w. 30% glucose solution.
After 8 weeks, animals were sacrificed as follows. First, blood pressure was measured by
cannulation of the carotid artery under general surgical anesthesia (pentobarbital, 45 mg/kg b.
w., i. p.). After perfusion via the carotid artery with heparinized Krebs-Ringer solution and
decapitation under anesthesia, the brain was removed and anterior cerebral artery (ACA) seg-
ments were prepared under a stereomicroscope (Wild M3Z, Heerbrugg, Switzerland). Heart
and testes were also removed for weight measurement.
Pressure microangiometry
An approximately 2-mm-long segment of the ACA was immersed into an organ chamber
(Experimetria Ltd., Budapest, Hungary) filled with normal Krebs-Ringer solution, cannulated
at both ends with microcannulas, and extended to its in vivo length. The chamber was placed
on the stage of an inverted microscope (Leica, Wetzlar, Germany). Pressure-servo pumps (Liv-
ing Systems, Burlington, VT, USA)–with the belonging pressure transducer (Living Systems,
Burlington, VT, USA), which had been calibrated with a mercurial manometer—were con-
nected to both cannulas and the arteries were pressurized to maintain 50 mmHg intraluminal
pressure. The cerebral arterioles were allowed to equilibrate for 30 min at this pressure in nor-
mal Krebs-Ringer solution bubbled with a gas mixture containing 5% CO2, 20% O2 and 75%
N2, and the temperature was kept at 37˚C during the entire measurement. After equilibration,
10−4 mol/L UTP was added to the chamber and after a 5-min incubation the pressure was
increased to 150 mmHg, then decreased to 0 mmHg; this challenge was then repeated once
more. Thereafter, the pressure was increased from 0 to 150 mmHg in 10 mmHg steps. All
these procedures were performed rapidly—within 5 minutes—to avoid activation of the myo-
genic response. After the arterioles were allowed to equilibrate at 50 mmHg intraluminal pres-
sure for 10 min, 10−6 mol/L bradykinin was added to the vessel chamber and incubated for 5
min at 50 mmHg intraluminal pressure in order to evaluate endothelium-dependent vasore-
laxation [13]. Finally, the passive diameter of vessels was measured: the organ chamber was
filled with Ca2+-free Krebs solution and after 20 min the pressure-diameter relationship was
determined as described above. Pictures were taken during the experiment by a digital camera
(Leica DFC 320) connected to the microscope. The outer and inner diameters of the vessels
were measured by ImageJ image analysis software (Image J 1.5 NIH, USA). For the calibration,
a micrometer etalon (Wild, Heerbrugg, Switzerland) was used.
Calculations
Wall thickness was expressed as the difference between the outer and inner radii: h = Ro-Ri,
where h is wall thickness, Ro is the outer radius and Ri is the inner radius. The wall cross-sec-
tional area (Aw) was computed according to the following equation: Aw = (Ro2-Ri2)π. Tangen-
tial wall stress was computed according to the Laplace-equation: σtang = (PRi)/h, where σtang is
the tangential wall stress and P is the intraluminal pressure. The elastic modulus was computed
as: E = (ΔP/ΔRo)2Ri2Ro/(Ro2-Ri2), where E is the incremental elastic modulus, ΔP is the
change in intraluminal pressure and ΔRo is the outer radius change in response to ΔP.
Cerebrovascular disorders in vitamin D deficiency
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Incremental distensibility was computed as D = ΔV/VΔP, where D is the incremental dis-
tensibility and ΔV is the change in lumen volume relative to the initial volume V in response to
pressure change (ΔP). Myogenic tone was computed as M% = 100(RiCf-RinKR)/RiCf, where
RiCf is the inner radius in Ca2+-free solution and RinKR is the inner radius in normal Krebs-
Ringer solution. UTP-induced contraction was expressed as a percentage of complete relaxa-
tion: TUTP% = 100(RiCf-RiUTP)/RiCf, where RiUTP is the inner radius after incubation with
UTP. Bradykinin-induced relaxation was expressed as a percentage of UTP-induced precon-
traction: TBK% = 100(RiBK-RiUTP)/RiUTP, where RiBK is the inner radius after bradykinin was
added to the chamber.
Histology and immunohistochemistry
ACA segments were freshly fixed with formalin for histological examination and stained for
elastic fibers with Weigert’s resorcin-fuchsin. Paraffin-embedded sections of ACA were immu-
nostained with anti-COX-2 antibody (1:500, 1 h, 37˚C) or with anti-eNOS antibody (1:200, 1
h, 37˚C) after deparaffinization and antigen retrieval (0.1 mmol/L citrate buffer, pH 6, 30 min,
60˚C). Endogenous peroxidase activity was quenched (with hydrogen-peroxide dissolved in
distilled water) and blocked (2.5% normal horse serum). After secondary antibody (biotiny-
lated horse anti-mouse antibody for COX-2 or biotinylated horse anti-rabbit antibody for
eNOS) staining (30 min, RT) the binding sites of primary antibodies were visualized with DAB
Substrate Kit (with 3,3’-diaminobenzidine; 6 min, RT). Sections were counterstained by hema-
toxylin. Artery segments were stained for smooth muscle actin (36 min, 37˚C) using Ventana
Benchmark Ultra System after deparaffinization and antigen retrieval (8 min, 97˚C). Ultra-
View Universal DAB Detection Kit was used for detecting primary antibodies. Data collections
were made by microscope (Zeiss AxioImager.A1) coupled with video-camera (Zeiss AxioCAm
MRc5 CCD). RGB pictures of resorcin-fuchsin-stained segments were analyzed with the Leica
Qwin image analysis software. The green levels (green color was chosen after evaluation of
color histograms) were measured starting at the luminal surface and going radially in an out-
ward direction. In addition, the thicknesses of the intimal and medial layers of arteries and the
intima/media ratio were determined. Pictures of smooth muscle actin, eNOS and COX-2
staining were analyzed with the ImageJ image analysis software using the „Color deconvolu-
tion” profile. Optical density of the endothelial layer after eNOS and COX-2 staining and the
nucleus count of tunica media after demarcation with smooth muscle actin staining were
determined.
Statistical analysis
All data are presented as mean±SEM. For statistical analysis Student’s t test or two-way
repeated measures ANOVA followed by Bonferroni post hoc test was used; p<0.05 was con-
sidered to be statistically significant. GraphPad Prism version 6.0 was used as statistical
software.
Materials
Vigantol 20.000 IU/mL was obtained from Merck Serono (Mumbai, India). Vitamin D defi-
cient (EF R/M, E15312-24) and conventional rat chow (SM R/M, S8106-S011) were purchased
from ssniff Spezialdia¨ten GmbH (Soest, Germany). Pentobarbital was obtained from Ceva-
Phylaxia (Budapest, Hungary). The composition of normal Krebs-Ringer solution (in mmol/
L) was: NaCl 119; KCl 4.7; NaH2PO4 1.2; MgSO4 1.17; NaHCO3 24; CaCl2 2.5; glucose 5.5 and
EDTA 0.034. The composition of Ca2+-free Krebs solution (in mmol/L) was: NaCl 92; KCl 4.7;
NaH2PO4 1.18; MgCl2 20; MgSO4 1.17; NaHCO3 24; glucose 5.5; EGTA 2 and EDTA 0.025.
Cerebrovascular disorders in vitamin D deficiency
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Uridine 5’-triphosphate (UTP) and bradykinin were purchased from Sigma-Aldrich (Darm-
stadt, Germany). Anti-eNOS [14] and anti-COX-2 [14] antibodies were obtained from Abcam
(Cambridge, MA, USA). Anti-smooth muscle actin antibody (1A4) [15] and UltraView Uni-
versal DAB Detection Kit were obtained from Ventana Medical Systems, Inc. (Tucson, AZ,
USA). Secondary antibodies and DAB Substrate Kit [14] were purchased from Vector Labora-
tories (Burlingame, CA, USA).
Results
Physiological parameters and serum levels of hormones,
25-hydroxyvitamin D and glucose
At the end of the experiments the measured physiological parameters of the rats (body weight,
heart/body weight ratio, testis weight, mean arterial blood pressure, heart rate, as well as serum
testosterone, androstenedione and progesterone levels) did not differ between the two groups
(Table 1), indicating that the VitD-deficient diet, at least within 8 weeks, does not affect these
parameters. To assess the efficacy of VitD deprivation, serum 25-hydroxyvitamin D levels
were measured and found to be significantly lower in VDD as compared to control animals at
the 8th week of treatment (Table 1). In the glucose tolerance test performed at the 6th week of
treatment, blood glucose levels before and after oral glucose administration did not show any
difference between the two groups (Table 1). These findings exclude the possibility that any
morphological or functional changes of the ACA in the present study would be secondary con-
sequences of VDD-induced hypertension, metabolic syndrome or altered androgenic hor-
mone status.
Table 1. Physiological parameters and serum levels of hormones, 25-hydroxyvitamin D and glucose in the two
experimental groups.
MEASURED PARAMETER CONTROL
n = 11
VDD
n = 11
Body weight (g) 435.7±17.7 444.5±10.3
Heart/body weight 0.34±0.01 0.34±0.01
Testis weight (g) 3.74±0.16 3.71±0.33
Mean arterial blood pressure (mmHg) 131±4 134±4
Heart rate (1/min) 357±18 348±11
Serum testosterone (ng/mL) 6.56±0.84 5.94±0.91
Serum androstenedione (ng/mL) 0.57±0.14 0.54±0.12
Serum progesterone (ng/mL) 14.42±2.31 19.86±2.61
Serum 25-hydroxyvitamin D (ng/mL) 19.66±0.81 3.59±0.21 
Glucose (OGTT 0 min) (mmol/L) 6.24±0.46 5.49±0.20
Glucose (OGTT 60 min) (mmol/L) 7.61±0.33 7.59±0.37
Glucose (OGTT 120 min) (mmol/L) 5.51±0.39 5.41±0.31
The body and testis weight as well as the heart/body weight ratio of rats did not differ between the groups. VDD did
not influence the mean arterial blood pressure, the heart rate or the serum hormone levels. Serum levels of glucose
did not show any significant difference between the two groups during the oral glucose tolerance test (OGTT). The
VitD-deficient diet induced significantly lower serum 25-hydroxyvitamin D level ( p<0.0001). All parameters
except blood glucose levels were measured at the 8th week of treatment. OGGT was performed at week 6. Data are
presented as mean±SEM.
 p<0.0001
https://doi.org/10.1371/journal.pone.0192480.t001
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Arterial geometry
The artery segments were examined in Ca2+-free Krebs solution with pressure myograph to
determine vessel geometry under passive conditions, as we hypothesized that a VitD-deficient
diet could cause remodeling of cerebral arteries. In Ca2+-free Krebs solution the artery seg-
ments showed their fully relaxed inner radii, which decreased tendentiously in the VDD as
compared to the Control group, but the difference did not reach the level of statistical signifi-
cance (89.6±6.3 μm for Control, 78.4±5.6 μm for VDD, at 50 mmHg intraluminal pressure).
However, wall thickness (Fig 1A) and wall thickness / lumen diameter ratio (Fig 1B) showed a
significant increase in the VDD group under passive conditions. In addition, VitD-deficient
Fig 1. Cerebral artery geometry and nucleus count of the smooth muscle layer. (A) VDD significantly increased the wall thickness ( p<0.05,
n = 10–11) as well as (B) the wall thickness / lumen diameter ratio ( p<0.01, n = 10–11). (C) The cross-sectional area of the vessel walls increased
significantly in VDD as compared to the Control group ( p<0.05, n = 9–9) at 50 mmHg intraluminal pressure. All these parameters were measured
under passive conditions. (D) Significantly more nuclei were detected in the smooth muscle layer of anterior cerebral arteries of VDD animals as
compared to controls ( p<0.0001, n = 4–6). (E) The thickness of the tunica media was increased in the VDD group as compared to the control
animals ( p<0.05, n = 4–4). (F) In addition, VDD significantly decreased the intima / media ratio of cerebral arteries ( p<0.05, n = 4–4).
https://doi.org/10.1371/journal.pone.0192480.g001
Cerebrovascular disorders in vitamin D deficiency
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feeding increased the wall cross-sectional area as compared to the Control group (Fig 1C),
indicating the development of hypertrophic remodeling in the VDD group.
Arterial elasticity
As previously mentioned, the wall thickness / lumen diameter ratio increased in the arterioles
of the VDD group. In accordance with this finding, the tangential wall stress was significantly
lower in the VDD group under passive conditions (Fig 2), as this biomechanical parameter is
inversely proportional to the wall-to-lumen ratio. The incremental elastic modulus and the
distensibility did not change significantly between the groups at 50 mmHg intraluminal pres-
sure measured under passive conditions (elastic modulus: 2.89±0.27 log(kPa) and 2.65±0.19
log(kPa), distensibility: 1.41±0.12 log(Pa-1) and 1.18 ± 0.23 log(Pa-1) for the Control and VDD
groups, respectively).
Smooth muscle tone and endothelial reactivity
ACA possesses myogenic tone under resting conditions as well [16]. In our present experi-
ment, the myogenic tone values of excised ACA segments were determined at 50 mmHg intra-
luminal pressure. Segments from VDD animals showed a two-fold increase in myogenic tone
as compared to control ones, indicating that the 8-week VitD deprivation doubled the sponta-
neous tone of vessels (Fig 3A). Because UTP is a potent vasoconstrictor of cerebral arteries
[17], the agonist-induced responsiveness with this agent was also tested at 50 mmHg intralum-
inal pressure. UTP caused potent constriction in both groups, but the induced tone was signifi-
cantly greater in the VDD group (Fig 3B). To evaluate endothelial function, bradykinin was
applied after precontraction with UTP. Whereas bradykinin induced slight vasodilatation in
the Control group, it failed to relax the arteries from the VDD group (Fig 3C), indicating endo-
thelial dysfunction in VitD-deficient animals.
Fig 2. The tangential wall stress of the cerebral arteries in relaxed condition. VDD caused a decrease in the
tangential stress of the vessel wall throughout the entire pressure range under passive conditions ( p<0.05, n = 10–11).
https://doi.org/10.1371/journal.pone.0192480.g002
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PLOS ONE | https://doi.org/10.1371/journal.pone.0192480 February 6, 2018 7 / 16
Histology and immunohistochemistry
To gain further insight into the mechanism responsible for the above-mentioned observations,
the density of the elastic components of the vessel wall was determined using resorcin-fuchsin
staining, which did not show any difference between the groups based on the green color den-
sity measurements made in radial direction, outward from the luminal surface (Fig 4A and
4B). Furthermore, after immunohistological staining of smooth muscle actin the amount of
nuclei was determined in the tunica media. The significantly increased nucleus count found in
the smooth muscle layer of arteries from the VDD group (Fig 1D) indicated the presence of
more vascular smooth muscle cells (VSMCs) in the vessel wall of VitD-deficient animals.
Related to this alteration, increased thickness of the tunica media of arteries was observed
in the VDD group (Fig 1E), however VDD did not affect the thickness of tunica intima
(3.15±0.19 μm for Control, 3.15±0.24 μm for VDD). Therefore, VDD decreased the intima /
media ratio of ACA (Fig 1F). To evaluate the possible role of NO and prostanoids in the effect
of VDD, the expression of eNOS and COX-2 was determined by immunostaining. The optical
Fig 3. Alterations of vascular reactivity in VDD. VDD caused alterations in the smooth muscle tone and endothelium-dependent relaxation capacity
of arterioles. (A) Anterior cerebral arteries possessed myogenic tone and this tone was greater in the VDD group measured at 50 mmHg intraluminal
pressure ( p<0.01, n = 8–8). (B) In addition, UTP-induced contraction also increased in the VDD group at 50 mmHg intraluminal pressure
( p<0.05, n = 10–9). (C) Bradykinin induced endothelium-dependent relaxation after precontraction in the Control group, but did not relax the
arterioles in the VDD group at 50 mmHg intraluminal pressure ( p<0.05, n = 9–9).
https://doi.org/10.1371/journal.pone.0192480.g003
Cerebrovascular disorders in vitamin D deficiency
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density of endothelial eNOS staining was lower in the VDD group, indicating lower expression
of eNOS (Fig 5A and 5B). In contrast, COX-2 expression was enhanced in the endothelial
layer of arteries from the VDD group (Fig 5C and 5D).
Discussion
To our knowledge, the present study provides the first report of the deleterious changes in
geometry and reactivity of cerebral arteries due to VDD. These alterations were associated
with hypertrophic remodeling, increased myogenic tone, endothelial dysfunction, increased
COX-2 and decreased eNOS expression. Interestingly, marked changes of morphology and
reactivity developed in healthy young adult animals within a relatively short period (8 weeks)
of VDD indicating the importance of normal VitD status for the maintenance of cerebrovascu-
lar functions.
In humans, the cardiovascular consequences of VDD include hypertension, atherosclerosis,
cardiac hypertrophy, cerebrovascular diseases, coronary artery disease, peripheral artery dis-
ease, dyslipidemia, insulin resistance and diabetes mellitus [2]; in addition, VDD during preg-
nancy leads to cardiomyopathy in infants [2, 18]. However, the associations, for instance,
between VDD and insulin resistance [19, 20] or between VDD and hypertension [21] are not
fully confirmed, especially in young healthy subjects [22–24]. The cardiovascular impacts of
VitD are attributed to the modulation of immune, inflammatory and endothelial functions,
furthermore to the regulation of VSMC proliferation and migration, renin expression, and
extracellular matrix homeostasis [2].
In rodent models of VDD similar disorders of the cardiovascular system have been
described as in humans, although their manifestation depends markedly on the experimental
protocol applied. For instance, in a number of studies hypertension developed as a conse-
quence of VDD, whereas the blood pressure remained unaltered in other studies (Table 2).
According to the literature, VDD during the prenatal period leads to increased blood pressure
in rodents’ offsprings [25–29] probably due to the upregulation of the renin-angiotensin
system [18, 30]. Interestingly, VDD in utero contributes to the development of hypertension
in later life even if the offsprings were fed with VitD sufficient chow after weaning [25, 26],
which implies that VDD during pregnancy can severely impact the offspring’s long-term
health and lead to vulnerability to cardiovascular disease in adult life [18, 31]. However, when
VDD affects only the postnatal period of life, the observations are controversial both in grow-
ing and adult rodents; nevertheless longer exposure to VDD appears to increase the risk of
Fig 4. Elastic components of the vessel wall. (A) Representative images of cerebral arterioles stained with Weigert’s
resorcin-fuchsin. (B) Elastic fiber density did not differ between the groups according to measurement of green color
intensity as a function of distance from the luminal surface measured on resorcin-fuchsin-stained segments.
https://doi.org/10.1371/journal.pone.0192480.g004
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manifestation of hypertension [25, 32–38]. Taken together, the development of hypertension
appears to depend on the time of onset and the duration of VDD (Table 2). In our study, wean-
ling rats were exposed to VDD for only 8 weeks, which explains the unaltered blood pressure
levels. Although VDD is a complex disorder linked to several cardiovascular risk factors in the
long run, we examined its short-term effects, and found altered cerebrovascular morphology
and reactivity without the development of hypertension.
Surprisingly, in spite of the well-preserved systemic cardiovascular and metabolic parame-
ters, marked inward hypertrophic remodeling was observed in the cerebral arteries of VDD
animals, similar to that observed in secondary hypertension [39]. In rats and humans suffer-
ing from secondary hypertension the increase in the wall-to-lumen ratio of small vessels is
due to hypertrophic remodeling as a consequence of smooth muscle cell proliferation [39,
40]. In contrast, the hypertrophic remodeling observed in our present study develops at
normal blood pressure and therefore is likely to be the direct effect of VDD on VSMCs.
1,25-dihydroxyvitamin D can modulate VSMC proliferation and migration [4]. In our study
Fig 5. Evaluation of immunohistochemical staining of arterioles. (A) Representative immunohistochemical images of cerebral arterioles stained
for eNOS. (B) VDD caused a decrease in the expression of eNOS in the endothelium of arterioles ( p<0.05, n = 4–6). (C) Representative
immunohistochemical images of cerebral arterioles stained for COX-2. (D) The expression of COX-2 in the endothelial layer increased in VDD as
compared to Control ( p<0.05, n = 4–4).
https://doi.org/10.1371/journal.pone.0192480.g005
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the increased cross-sectional area of the vessel wall appears to be the consequence of VSMC
proliferation, because we observed increased number of smooth muscle cells in the tunica
media of VitD-deficient arteries as compared to controls. On the contrary, we did not
observe any changes in the tunica intima of arteries from the VDD group. The literature is
controversial regarding the effects of VitD on VSMC proliferation and migration: some stud-
ies report enhanced migration and proliferation [41, 42], whereas others found VitD-induced
inhibition of VSMC growth [43, 44]. VitD could inhibit VSMC proliferation via blunting c-
myc RNA induction [42], up-regulating the negative modulators of cell proliferation includ-
ing TGF-β [45] or decreasing cyclin-dependent kinase 2 activity [46]. The effect of VitD on
VSMC definitely depends on the applied dose, and both insufficient and supraphysiological
levels of VitD appear to lead to VSMC proliferation. In accordance, U-shaped association has
been reported between VitD concentrations and cardiovascular diseases [4] [47]. Therefore,
only physiological concentrations of VitD appear to be appropriate for maintaining normal
VSMC function.
In hypertension, increased tangential wall stress facilitates wall thickening to compensate
increased circumferential stress [48]. In our study, however, mean arterial blood pressure
did not differ between the groups, thus the observed wall thickening resulted in decreased tan-
gential wall stress according to the Laplace equation. The incremental elastic modulus and dis-
tensibility did not differ between the groups, indicating that elastic element density and
arrangement were not influenced by VDD. This presumption was also confirmed by the unal-
tered elastic fiber density.
Cerebral arteries possess intrinsic myogenic tone [16], which can increase harmfully under
pathophysiological conditions. In our study, arteries of VitD-deficient animals developed
greater myogenic tone, which is similar to the observation of Tare et al., who reported a two-
fold enhancement of the myogenic tone of mesenteric arteries in male VitD-deficient rats as
compared to VitD-sufficient ones [29]. In addition, UTP—a potent and partly thromboxane
A2-mediated constrictor of cerebral arteries [49]—induced greater tone in the ACA of VDD
animals. VitD is an important modulator of the prostanoid system, since it downregulates the
expression of COX-2 [50], therefore VDD can lead to enhanced COX-2 expression, as we
found in the endothelium of cerebral arteries. In addition, VitD suppresses the expression of
Table 2. Alterations of blood pressure in rodent models of VDD induced by VitD deficient feeding.
ONSET OF VDD DURATION OF VDD
(day)
SPECIES, STRAIN
(M: mouse, R: rat)
INCREASE OF BLOOD PRESSURE
(mmHg)
[reference]
Prenatal 20 R, Sprague-Dawley +15 [25]
Prenatal 30 M, Swiss Webster +25 [26]
Prenatal 76 R, Sprague-Dawley +10 [29]
Prenatal 76 M, C57BL/6 J + 20 [28]
Prenatal 200 M, BALB/c +15 [27]
Juvenile 21 R, Sprague-Dawley NO [32]
Juvenile 84 R, Wistar +20 [33]
Juvenile 119 R, Lewis/SSN NO [37]
Juvenile 196 R, Sprague-Dawley +30 [38]
Adolescent 90 R, Wistar +15 [35]
Pubescent 60 R, Wistar NO [34]
Adult 28 R, Wistar +10 [36]
Adult 70 R, Sprague-Dawley NO [25]
https://doi.org/10.1371/journal.pone.0192480.t002
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TNF-α, NADPH oxidase and its subunits and also increases CuZn-SOD protein expression,
therefore prevents inflammatory response and oxidative stress [51]. The increased level of
reactive oxygen species (ROS) in VDD can in turn lead to enhanced vasoconstrictor response,
as ROS inactivate prostacyclin synthase, shifting the prostanoid balance towards vasoconstric-
tion [52]. Bradykinin relaxes cerebral arteries via the B2 receptor and NO release [13]; how-
ever, in the case of endothelial dysfunction bradykinin can cause endothelium-independent
contractions [53]. VitD stimulates NO production through non-genomic eNOS activation via
increase in eNOS phosphorylation [54] or due to an increase in eNOS mRNA and promoter
activity depending on VitD receptor activation [55]. In our study, we observed decreased
eNOS expression in the endothelium of VDD animals, which could contribute to the increased
vessel tone and the impaired endothelium-dependent relaxation capacity. In the case of endo-
thelial dysfunction, bradykinin-induced contractions might be mediated by COX-2 derived
prostanoids and activation of thromboxane-prostanoid receptors [53]. The activation of
thromboxane-prostanoid receptors could in turn impair the NO-mediated dilatation of vessels
as well [56]. In addition, ROS can also contribute to the diminished endothelium-dependent
vasodilatation in VDD due to eNOS uncoupling or inactivation of NO [57]. Enhanced vaso-
constrictor prostanoid release and the impairment of the counterbalancing NO pathway could
lead to increased myogenic tone and constrictor response as well as endothelial dysfunction in
VDD.
VDD influences several pathways relevant to vascular physiology and pathophysiology,
therefore it appears to be a significant risk factor for cardiovascular and cerebrovascular dis-
ease [2]. Since VDD is associated with dysfunction of endothelial and vascular smooth muscle
cells, low VitD levels could predict proinflammatory and prothrombotic alterations, which
might lead to atherosclerosis as well as increased thrombosis and arterial stiffness [2, 58].
VDD is not only a risk factor for coronary disease, acute myocardial infarction and stroke [2,
5, 59], but it also worsens the outcome when myocardial infarction and stroke are already
present [10, 59]. In addition, low levels of VitD are associated with cerebral small vessel dis-
ease related vascular dementia [60, 61] and arterial stiffness associated cognitive impairment
[62]. The observed alterations in cerebrovascular geometry and reactivity can be considered
as prehypertensive changes [39]. Furthermore, the endothelial dysfunction of arteries may
lead to the development of atherosclerosis in the long run, as the reduction of biosynthesis
and enhanced inactivation of prostacyclin and NO are key components in the initiation of
atherogenesis [63]. In addition, the increase in COX-2 expression as well as the proliferation
of smooth muscle cells are also predictive of the development of atherosclerosis [63]. There-
fore, long-term VDD with or without other disturbing pathophysiological conditions can in
turn contribute to hypertension, atherosclerosis and a further increase in constrictor tone as
well as to a more deleterious impairment of relaxation capacity, which can aggravate the risk
of stroke events [64].
Conclusions
The present study demonstrates the harmful effects of VDD on cerebral artery geometry and
function in a rat model. We propose that VDD results in inward hypertrophic remodeling due
to VSMC proliferation as well as in enhanced vessel tone due to increased vasoconstrictor
prostanoid levels. In addition, impaired NO-mediated vasodilatation leads to endothelial dys-
function. Our results imply that a relatively short-term VDD in a relatively young age without
any comorbidities can already induce marked morphological and functional alterations in the
cerebral vasculature, which underlines the importance of sufficient VitD supply throughout
the entire life in order to prevent stroke and other cerebrovascular diseases.
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